Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a new release or patch was applied. This appears to be an internal versioning update rather than a user-visible content change.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA revision/version label on the page footer was updated from v3.5.2 to v3.5.3, reflecting a technical software release rather than a change to the represented clinical trial information.SummaryDifference0.0%

- Check41 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Mucosa-associated lymphoma and B-cell chronic lymphocytic leukemia to the list of diseases relevant to the study.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check84 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. No visible changes to study details or page content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.